Page 259 - IJB-8-4

Akter, et al.
https://doi.org/10.1001/jama.2020.1585 Disease 2019 From a Nationwide Analysis in China. Chest,
57. Zhang J, Wang X, Jia X, et al., 2020, Risk Factors for Disease 158:97–105.
Severity, Unimprovement, and Mortality in COVID-19 https://doi.org/10.1016/j.chest.2020.04.010
Patients in Wuhan, China. Clin Microbiol Infect, 26:767–72. 69. Yang X, Yu Y, Xu J, et al., 2020, Clinical Course and Outcomes
https://doi.org/10.1016/j.cmi.2020.04.012 of Critically Ill Patients with SARS-CoV-2 Pneumonia
58. Ebinger JE, Achamallah N, Ji H, et al., 2020, Pre-Existing in Wuhan, China: A Single-Centered, Retrospective,
Traits Associated with Covid-19 Illness Severity. PLoS One, Observational study. Lancet Respir Med, 8:475–81.
15:e0236240. https://doi.org/10.1016/S2213-2600(20)30079-5
https://doi.org/10.1371/journal.pone.0236240 70. Grasselli G, Zangrillo A, Zanella A, et al., 2020, Baseline
59. Du H, Dong X, Zhang JJ, et al., 2021, Clinical Characteristics Characteristics and Outcomes of 1591 Patients Infected with
of 182 Pediatric COVID-19 Patients with Different Severities SARS-CoV-2 Admitted to ICUs of the Lombardy Region,
and Allergic Status. Allergy, 76:510–32. Italy. JAMA, 323:1574–81.
https://doi.org/10.1111/all.14452 https://doi.org/10.1001/jama.2020.5394
60. Bompard F, Monnier H, Saab I, et al., 2020, Pulmonary 71. Hu L, Chen S, Fu Y, et al., 2020, Risk Factors Associated
Embolism in Patients with COVID-19 Pneumonia. Eur with Clinical Outcomes in 323 Coronavirus Disease 2019
Respir J, 56:17–20. (COVID-19) Hospitalized Patients in Wuhan, China. Clin
https://doi.org/10.1183/13993003.01365-2020 Infect Dis, 71:2089–98.
61. Liu J, Li S, Liu J, et al., 2020, Longitudinal Characteristics https://doi.org/10.1093/cid/ciaa539
of Lymphocyte Responses and Cytokine Profiles in the 72. Zhang JJ, Dong X, Cao YY, et al., 2020, Clinical
Peripheral Blood of SARS-CoV-2 Infected Patients. Characteristics of 140 Patients Infected with SARS-CoV-2 in
EBioMedicine, 55:0102763. Wuhan, China. Allergy, 75:1730–41.
https://doi.org/10.1016/j.ebiom.2020.102763 https://doi.org/10.1111/all.14238
62. d’Alessandro M, Cameli P, Refini RM, et al., 2020, Serum 73. Li X, Xu S, Yu M, et al., 2020, Risk Factors for Severity and
KL-6 Concentrations as a Novel Biomarker of Severe Mortality in Adult COVID-19 Inpatients in Wuhan. J Allergy
COVID-19. J Med Virol, 92:2216–20. Clin Immunol, 146:110–8.
https://doi.org/10.1002/jmv.26087 https://doi.org/10.1016/j.jaci.2020.04.006
63. Rai DK, Sharma P, Kumar R, 2021, Post Covid 19 Pulmonary 74. Zheng Z, Peng F, Xu B, et al., 2020, Risk Factors of Critical
Fibrosis. Is it Real Threat? Indian J Tuberc, 68:330–3. and Mortal COVID-19 Cases: A Systematic Literature
https://doi.org/10.1016/j.ijtb.2020.11.003 Review and Meta-Analysis. J Infect, 81:e16–25.
64. Ojo AS, Balogun SA, Williams OT, et al, 2020, Pulmonary https://doi.org/10.1016/j.jinf.2020.04.021
Fibrosis in COVID-19 Survivors: Predictive Factors and Risk 75. Riccardo F, Ajelli M, Andrianou XD, et al., 2020,
Reduction Strategies. Pulm Med, 2020:6175964. Epidemiological Characteristics of COVID-19 Cases and
https://doi.org/10.1155/2020/6175964 Estimates of the Reproductive Numbers 1 Month into the
65. Sohrabi C, Alsafi Z, O’Neill N, et al., 2020, World Health Epidemic, Italy, 28 January to 31 March 2020. Euro Surveill,
Organization Declares Global Emergency: A Review of the 25:2000790.
2019 Novel Coronavirus (COVID-19). Int J Surg, 76:71–6. https://doi.org/10.2807/1560-7917.ES.2020.25.49.2000790
https://doi.org/10.1016/j.ijsu.2020.02.034 76. Stokes EK, Zambrano LD, Anderson KN, et al., 2020,
66. Chen N, Zhou M, Dong X, et al., 2020, Epidemiological Coronavirus Disease 2019 Case Surveillance-United States,
and Clinical Characteristics of 99 Cases of 2019 Novel January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep,
Coronavirus Pneumonia in Wuhan, China: A Descriptive 69:759–65.
Study. Lancet (London, England), 395:507–13. https://doi.org/10.15585/mmwr.mm6924e2
https://doi.org/10.1016/S0140-6736(20)30211-7 77. Cao M, Zhang D, Wang Y, et al., 2020, Clinical Features of
67. Opal SM, Girard TD, Ely EW, 2005, The Immunopathogenesis Patients Infected with the 2019 Novel Coronavirus (COVID-19)
of Sepsis in Elderly Patients. Clin Infect Dis, 41:S504–12. in Shanghai, China. medRxiv, 2020:2020.03.04.20030395.
https://doi.org/10.1086/432007 https://doi.org/10.1101/2020.03.04.20030395
68. Chen R, Liang W, Jiang M, et al., 2020, Risk Factors of 78. Jin JM, Bai P, He W, et al., 2020, Gender Differences in
Fatal Outcome in Hospitalized Subjects with Coronavirus Patients With COVID-19: Focus on Severity and Mortality.

International Journal of Bioprinting (2022)–Volume 8, Issue 4 251